| Dr Terrence J Forster, MD | |
|
4 Terry Dr, Suite 10a, Newtown, PA 18940-1838 | |
| (215) 968-6000 | |
| (215) 968-9287 |
| Full Name | Dr Terrence J Forster |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Clinical & Laboratory Immunology |
| Location | 4 Terry Dr, Newtown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639132483 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terrence J Forster, MD 4 Terry Dr, Suite 10a, Newtown, PA 18940-1838 Ph: (215) 968-6000 | Dr Terrence J Forster, MD 4 Terry Dr, Suite 10a, Newtown, PA 18940-1838 Ph: (215) 968-6000 |
News Archive
Depomed, Inc. today announced that it has closed the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion. The NUCYNTA franchise includes: NUCYNTA ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), severe enough to require daily, around-the-clock, long-term opioid treatment; NUCYNTA (tapentadol), an immediate release version of tapentadol, for management of moderate to severe acute pain in adults; and NUCYNTA (tapentadol) oral solution, an approved oral form of tapentadol that has not been launched.
CSL Behring, a global leader in the plasma-protein biotherapeutics industry, is calling for grant requests through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program awards funds to United States patient organizations that assist people with rare diseases in advocating for continued access to health care and life-saving plasma protein therapies.
A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory, according to a new study by the UCLA AIDS Institute.
This new NGS panel molecular test is an important step towards readily accessible and affordable personalized medicine in cancer...
MicroCHIPS, Inc., a developer of intelligent implant systems, today announced that it has received a 2010 Edison Best New Product Award for its Illume product. The product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy.
› Verified 9 days ago
Richard A Schwarz, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4 Terry Dr, Suite 10a, Newtown, PA 18940 Phone: 215-968-6000 Fax: 215-968-6000 | |
Dr. Stephanie Ann Knapp, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4 Terry Dr, Suite 10a, Newtown, PA 18940 Phone: 215-968-6000 Fax: 215-968-9287 |